Global Non-Invasive Glucose Meter

Non-Invasive Glucose Meter Comprehensive Study by Type (Wearable, Non-Wearable), Application (Hospitals, Home Care Settings, Clinics, Others), Technology (MIR/NIR (Mid/Near Infrared Spectroscopy), Raman Spectroscopy, Occlusion Spectroscopy, Optical Coherence Tomography, Thermal Emission Spectroscopy, Photoacoustic Spectroscopy, Impedance/Dielectric Spectroscopy, Polarimetry, Fluorescence) Players and Region - Global Market Outlook to 2024

Non-Invasive Glucose Meter Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Non-Invasive Glucose Meter Market Overview:
The Non-invasive glucose meter are the devices used to monitor the characterization of the biological properties of the skin or biological fluids such as saliva or tears that can be used to track glucose changes in strictly controlled condition. Major driving factors for the non-invasive glucose meter market is expected to increase incidence of diabetes and risk factors associated with it such as binge eating and sedentary lifestyle. This factor is expected to boost the global market. The major companies are adding more proven technologies systematically and strategically in Asia-Pacific countries as these countries are focused on fastest-growing verticals in the healthcare infrastructure.

Market Drivers
  • Increasing Number of Elderly Population Suffering From Diabetes.
  • Rapid Growth of Non-Invasive Glucose Meter in Household Application.

Market Trend
  • Value Oriented Consumers
  • Substitutes Available For Non-invasive glucose meter

Restraints
  • High Devices Cost Associated With Non-Invasive Glucose Meter.
  • The Non-Invasive Glucose Meters Are Not Providing Point Accuracy.

Opportunities
  • Technology Advancement In Non-Invasive Glucose Meter To Measure The Blood Level Through Sensor.
  • The Non-Invasive Glucose Meter Lacks In Sensitivity Due To Substantial Physical and Chemical Interference.

Challenges
  • Lack Of Skilled Professional Required For Operation Of Non-Invasive Glucose Meter.


Competitive Landscape:
In non-invasive glucose meter market, it has been observed that most of the companies are introducing sensor technology that used to monitor blood glucose levels with an accuracy.
Some of the key players profiled in the report are Abbott Laboratories (United States), Bayer Healthcare (Germany), Biophotonic Corporation (Taiwan), Cnoga Care, DexCom (United States), Integrity Applications Incorporate(United States), Life Scan (United States), MediWise (United Kingdom), Nemaura Medical Inc. (United Kingdom) and OrSense Ltd (Israel). Additionally, following companies can also be profiled that are part of our coverage like Roche Diagnostics (India) and Tech4Life Enterprises (Canada). Analyst at AdvanceMarketAnalytics see United States and United Kingdom Players to retain maximum share of Global Non-Invasive Glucose Meter market by 2024. Considering Market by Technology, the sub-segment i.e. MIR/NIR (Mid/Near Infrared Spectroscopy) will boost the Non-Invasive Glucose Meter market.

Market Highlights:

Abott launched a flash glucose monitoring system for diabetes patients which is beneficial in providing visual chart, enabling productive treatment discussions and easily detect the sugar levels go high and low over a typical 24 hour period.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Non-Invasive Glucose Meter market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Non-Invasive Glucose Meter market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Non-Invasive Glucose Meter Manufacturers, Non-Invasive Glucose Meter Traders, End-Use Market Participants of Different Segments of Non-Invasive Glucose Meter, Government and Research Organizations, Associations and Industrial Bodies, Research and Consulting Firms, R&D Institutions and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Wearable
  • Non-Wearable
By Application
  • Hospitals
  • Home Care Settings
  • Clinics
  • Others
By Technology
  • MIR/NIR (Mid/Near Infrared Spectroscopy)
  • Raman Spectroscopy
  • Occlusion Spectroscopy
  • Optical Coherence Tomography
  • Thermal Emission Spectroscopy
  • Photoacoustic Spectroscopy
  • Impedance/Dielectric Spectroscopy
  • Polarimetry
  • Fluorescence

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Elderly Population Suffering From Diabetes.
      • 3.2.2. Rapid Growth of Non-Invasive Glucose Meter in Household Application.
    • 3.3. Market Challenges
      • 3.3.1. Lack Of Skilled Professional Required For Operation Of Non-Invasive Glucose Meter.
    • 3.4. Market Trends
      • 3.4.1. Value Oriented Consumers
      • 3.4.2. Substitutes Available For Non-invasive glucose meter
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Non-Invasive Glucose Meter, by Type, Application, Technology and Region (value and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Non-Invasive Glucose Meter (Value)
      • 5.2.1. Global Non-Invasive Glucose Meter by: Type (Value)
        • 5.2.1.1. Wearable
        • 5.2.1.2. Non-Wearable
      • 5.2.2. Global Non-Invasive Glucose Meter by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Home Care Settings
        • 5.2.2.3. Clinics
        • 5.2.2.4. Others
      • 5.2.3. Global Non-Invasive Glucose Meter by: Technology (Value)
        • 5.2.3.1. MIR/NIR (Mid/Near Infrared Spectroscopy)
        • 5.2.3.2. Raman Spectroscopy
        • 5.2.3.3. Occlusion Spectroscopy
        • 5.2.3.4. Optical Coherence Tomography
        • 5.2.3.5. Thermal Emission Spectroscopy
        • 5.2.3.6. Photoacoustic Spectroscopy
        • 5.2.3.7. Impedance/Dielectric Spectroscopy
        • 5.2.3.8. Polarimetry
        • 5.2.3.9. Fluorescence
      • 5.2.4. Global Non-Invasive Glucose Meter Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Non-Invasive Glucose Meter (Price)
      • 5.3.1. Global Non-Invasive Glucose Meter by: Type (Price)
  • 6. Non-Invasive Glucose Meter: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer Healthcare (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Biophotonic Corporation (Taiwan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cnoga Care
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. DexCom (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Integrity Applications Incorporate(United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Life Scan (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. MediWise (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Nemaura Medical Inc. (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. OrSense Ltd (Israel)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Non-Invasive Glucose Meter Sale, by Type, Application, Technology and Region (value and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Non-Invasive Glucose Meter (Value)
      • 7.2.1. Global Non-Invasive Glucose Meter by: Type (Value)
        • 7.2.1.1. Wearable
        • 7.2.1.2. Non-Wearable
      • 7.2.2. Global Non-Invasive Glucose Meter by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Home Care Settings
        • 7.2.2.3. Clinics
        • 7.2.2.4. Others
      • 7.2.3. Global Non-Invasive Glucose Meter by: Technology (Value)
        • 7.2.3.1. MIR/NIR (Mid/Near Infrared Spectroscopy)
        • 7.2.3.2. Raman Spectroscopy
        • 7.2.3.3. Occlusion Spectroscopy
        • 7.2.3.4. Optical Coherence Tomography
        • 7.2.3.5. Thermal Emission Spectroscopy
        • 7.2.3.6. Photoacoustic Spectroscopy
        • 7.2.3.7. Impedance/Dielectric Spectroscopy
        • 7.2.3.8. Polarimetry
        • 7.2.3.9. Fluorescence
      • 7.2.4. Global Non-Invasive Glucose Meter Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Non-Invasive Glucose Meter (Price)
      • 7.3.1. Global Non-Invasive Glucose Meter by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Non-Invasive Glucose Meter: by Type(USD Million)
  • Table 2. Non-Invasive Glucose Meter Wearable , by Region USD Million (2013-2018)
  • Table 3. Non-Invasive Glucose Meter Non-Wearable , by Region USD Million (2013-2018)
  • Table 4. Non-Invasive Glucose Meter: by Application(USD Million)
  • Table 5. Non-Invasive Glucose Meter Hospitals , by Region USD Million (2013-2018)
  • Table 6. Non-Invasive Glucose Meter Home Care Settings , by Region USD Million (2013-2018)
  • Table 7. Non-Invasive Glucose Meter Clinics , by Region USD Million (2013-2018)
  • Table 8. Non-Invasive Glucose Meter Others , by Region USD Million (2013-2018)
  • Table 9. Non-Invasive Glucose Meter: by Technology(USD Million)
  • Table 10. Non-Invasive Glucose Meter MIR/NIR (Mid/Near Infrared Spectroscopy) , by Region USD Million (2013-2018)
  • Table 11. Non-Invasive Glucose Meter Raman Spectroscopy , by Region USD Million (2013-2018)
  • Table 12. Non-Invasive Glucose Meter Occlusion Spectroscopy , by Region USD Million (2013-2018)
  • Table 13. Non-Invasive Glucose Meter Optical Coherence Tomography , by Region USD Million (2013-2018)
  • Table 14. Non-Invasive Glucose Meter Thermal Emission Spectroscopy , by Region USD Million (2013-2018)
  • Table 15. Non-Invasive Glucose Meter Photoacoustic Spectroscopy , by Region USD Million (2013-2018)
  • Table 16. Non-Invasive Glucose Meter Impedance/Dielectric Spectroscopy , by Region USD Million (2013-2018)
  • Table 17. Non-Invasive Glucose Meter Polarimetry , by Region USD Million (2013-2018)
  • Table 18. Non-Invasive Glucose Meter Fluorescence , by Region USD Million (2013-2018)
  • Table 19. South America Non-Invasive Glucose Meter, by Country USD Million (2013-2018)
  • Table 20. South America Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 21. South America Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 22. South America Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 23. Brazil Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 24. Brazil Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 25. Brazil Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 26. Argentina Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 27. Argentina Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 28. Argentina Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 29. Rest of South America Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 30. Rest of South America Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 31. Rest of South America Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 32. Asia Pacific Non-Invasive Glucose Meter, by Country USD Million (2013-2018)
  • Table 33. Asia Pacific Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 34. Asia Pacific Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 35. Asia Pacific Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 36. China Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 37. China Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 38. China Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 39. Japan Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 40. Japan Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 41. Japan Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 42. India Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 43. India Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 44. India Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 45. South Korea Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 46. South Korea Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 47. South Korea Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 48. Taiwan Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 49. Taiwan Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 50. Taiwan Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 51. Australia Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 52. Australia Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 53. Australia Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 54. Rest of Asia-Pacific Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 55. Rest of Asia-Pacific Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 56. Rest of Asia-Pacific Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 57. Europe Non-Invasive Glucose Meter, by Country USD Million (2013-2018)
  • Table 58. Europe Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 59. Europe Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 60. Europe Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 61. Germany Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 62. Germany Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 63. Germany Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 64. France Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 65. France Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 66. France Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 67. Italy Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 68. Italy Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 69. Italy Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 70. United Kingdom Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 71. United Kingdom Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 72. United Kingdom Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 73. Netherlands Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 74. Netherlands Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 75. Netherlands Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 76. Rest of Europe Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 77. Rest of Europe Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 78. Rest of Europe Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 79. MEA Non-Invasive Glucose Meter, by Country USD Million (2013-2018)
  • Table 80. MEA Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 81. MEA Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 82. MEA Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 83. Middle East Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 84. Middle East Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 85. Middle East Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 86. Africa Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 87. Africa Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 88. Africa Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 89. North America Non-Invasive Glucose Meter, by Country USD Million (2013-2018)
  • Table 90. North America Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 91. North America Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 92. North America Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 93. United States Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 94. United States Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 95. United States Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 96. Canada Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 97. Canada Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 98. Canada Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 99. Mexico Non-Invasive Glucose Meter, by Type USD Million (2013-2018)
  • Table 100. Mexico Non-Invasive Glucose Meter, by Application USD Million (2013-2018)
  • Table 101. Mexico Non-Invasive Glucose Meter, by Technology USD Million (2013-2018)
  • Table 102. Non-Invasive Glucose Meter: by Type(USD/Units)
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Non-Invasive Glucose Meter: by Type(USD Million)
  • Table 114. Non-Invasive Glucose Meter Wearable , by Region USD Million (2019-2024)
  • Table 115. Non-Invasive Glucose Meter Non-Wearable , by Region USD Million (2019-2024)
  • Table 116. Non-Invasive Glucose Meter: by Application(USD Million)
  • Table 117. Non-Invasive Glucose Meter Hospitals , by Region USD Million (2019-2024)
  • Table 118. Non-Invasive Glucose Meter Home Care Settings , by Region USD Million (2019-2024)
  • Table 119. Non-Invasive Glucose Meter Clinics , by Region USD Million (2019-2024)
  • Table 120. Non-Invasive Glucose Meter Others , by Region USD Million (2019-2024)
  • Table 121. Non-Invasive Glucose Meter: by Technology(USD Million)
  • Table 122. Non-Invasive Glucose Meter MIR/NIR (Mid/Near Infrared Spectroscopy) , by Region USD Million (2019-2024)
  • Table 123. Non-Invasive Glucose Meter Raman Spectroscopy , by Region USD Million (2019-2024)
  • Table 124. Non-Invasive Glucose Meter Occlusion Spectroscopy , by Region USD Million (2019-2024)
  • Table 125. Non-Invasive Glucose Meter Optical Coherence Tomography , by Region USD Million (2019-2024)
  • Table 126. Non-Invasive Glucose Meter Thermal Emission Spectroscopy , by Region USD Million (2019-2024)
  • Table 127. Non-Invasive Glucose Meter Photoacoustic Spectroscopy , by Region USD Million (2019-2024)
  • Table 128. Non-Invasive Glucose Meter Impedance/Dielectric Spectroscopy , by Region USD Million (2019-2024)
  • Table 129. Non-Invasive Glucose Meter Polarimetry , by Region USD Million (2019-2024)
  • Table 130. Non-Invasive Glucose Meter Fluorescence , by Region USD Million (2019-2024)
  • Table 131. South America Non-Invasive Glucose Meter, by Country USD Million (2019-2024)
  • Table 132. South America Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 133. South America Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 134. South America Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 135. Brazil Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 136. Brazil Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 137. Brazil Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 138. Argentina Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 139. Argentina Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 140. Argentina Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 141. Rest of South America Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 142. Rest of South America Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 143. Rest of South America Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 144. Asia Pacific Non-Invasive Glucose Meter, by Country USD Million (2019-2024)
  • Table 145. Asia Pacific Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 146. Asia Pacific Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 147. Asia Pacific Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 148. China Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 149. China Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 150. China Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 151. Japan Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 152. Japan Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 153. Japan Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 154. India Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 155. India Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 156. India Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 157. South Korea Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 158. South Korea Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 159. South Korea Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 160. Taiwan Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 161. Taiwan Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 162. Taiwan Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 163. Australia Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 164. Australia Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 165. Australia Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 166. Rest of Asia-Pacific Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 167. Rest of Asia-Pacific Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 168. Rest of Asia-Pacific Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 169. Europe Non-Invasive Glucose Meter, by Country USD Million (2019-2024)
  • Table 170. Europe Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 171. Europe Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 172. Europe Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 173. Germany Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 174. Germany Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 175. Germany Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 176. France Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 177. France Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 178. France Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 179. Italy Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 180. Italy Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 181. Italy Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 182. United Kingdom Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 183. United Kingdom Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 184. United Kingdom Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 185. Netherlands Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 186. Netherlands Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 187. Netherlands Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 188. Rest of Europe Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 189. Rest of Europe Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 190. Rest of Europe Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 191. MEA Non-Invasive Glucose Meter, by Country USD Million (2019-2024)
  • Table 192. MEA Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 193. MEA Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 194. MEA Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 195. Middle East Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 196. Middle East Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 197. Middle East Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 198. Africa Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 199. Africa Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 200. Africa Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 201. North America Non-Invasive Glucose Meter, by Country USD Million (2019-2024)
  • Table 202. North America Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 203. North America Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 204. North America Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 205. United States Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 206. United States Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 207. United States Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 208. Canada Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 209. Canada Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 210. Canada Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 211. Mexico Non-Invasive Glucose Meter, by Type USD Million (2019-2024)
  • Table 212. Mexico Non-Invasive Glucose Meter, by Application USD Million (2019-2024)
  • Table 213. Mexico Non-Invasive Glucose Meter, by Technology USD Million (2019-2024)
  • Table 214. Non-Invasive Glucose Meter: by Type(USD/Units)
  • Table 215. Research Programs/Design for This Report
  • Table 216. Key Data Information from Secondary Sources
  • Table 217. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Non-Invasive Glucose Meter: by Type USD Million (2013-2018)
  • Figure 5. Global Non-Invasive Glucose Meter: by Application USD Million (2013-2018)
  • Figure 6. Global Non-Invasive Glucose Meter: by Technology USD Million (2013-2018)
  • Figure 7. South America Non-Invasive Glucose Meter Share (%), by Country
  • Figure 8. Asia Pacific Non-Invasive Glucose Meter Share (%), by Country
  • Figure 9. Europe Non-Invasive Glucose Meter Share (%), by Country
  • Figure 10. MEA Non-Invasive Glucose Meter Share (%), by Country
  • Figure 11. North America Non-Invasive Glucose Meter Share (%), by Country
  • Figure 12. Global Non-Invasive Glucose Meter: by Type USD/Units (2013-2018)
  • Figure 13. Global Non-Invasive Glucose Meter share by Players 2018 (%)
  • Figure 14. Global Non-Invasive Glucose Meter share by Players (Top 3) 2018(%)
  • Figure 15. Global Non-Invasive Glucose Meter share by Players (Top 5) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 18. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 19. Bayer Healthcare (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Bayer Healthcare (Germany) Revenue: by Geography 2018
  • Figure 21. Biophotonic Corporation (Taiwan) Revenue, Net Income and Gross profit
  • Figure 22. Biophotonic Corporation (Taiwan) Revenue: by Geography 2018
  • Figure 23. Cnoga Care Revenue, Net Income and Gross profit
  • Figure 24. Cnoga Care Revenue: by Geography 2018
  • Figure 25. DexCom (United States) Revenue, Net Income and Gross profit
  • Figure 26. DexCom (United States) Revenue: by Geography 2018
  • Figure 27. Integrity Applications Incorporate(United States) Revenue, Net Income and Gross profit
  • Figure 28. Integrity Applications Incorporate(United States) Revenue: by Geography 2018
  • Figure 29. Life Scan (United States) Revenue, Net Income and Gross profit
  • Figure 30. Life Scan (United States) Revenue: by Geography 2018
  • Figure 31. MediWise (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. MediWise (United Kingdom) Revenue: by Geography 2018
  • Figure 33. Nemaura Medical Inc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Nemaura Medical Inc. (United Kingdom) Revenue: by Geography 2018
  • Figure 35. OrSense Ltd (Israel) Revenue, Net Income and Gross profit
  • Figure 36. OrSense Ltd (Israel) Revenue: by Geography 2018
  • Figure 37. Global Non-Invasive Glucose Meter: by Type USD Million (2019-2024)
  • Figure 38. Global Non-Invasive Glucose Meter: by Application USD Million (2019-2024)
  • Figure 39. Global Non-Invasive Glucose Meter: by Technology USD Million (2019-2024)
  • Figure 40. South America Non-Invasive Glucose Meter Share (%), by Country
  • Figure 41. Asia Pacific Non-Invasive Glucose Meter Share (%), by Country
  • Figure 42. Europe Non-Invasive Glucose Meter Share (%), by Country
  • Figure 43. MEA Non-Invasive Glucose Meter Share (%), by Country
  • Figure 44. North America Non-Invasive Glucose Meter Share (%), by Country
  • Figure 45. Global Non-Invasive Glucose Meter: by Type USD/Units (2019-2024)
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Bayer Healthcare (Germany)
  • Biophotonic Corporation (Taiwan)
  • Cnoga Care
  • DexCom (United States)
  • Integrity Applications Incorporate(United States)
  • Life Scan (United States)
  • MediWise (United Kingdom)
  • Nemaura Medical Inc. (United Kingdom)
  • OrSense Ltd (Israel)
Additional players considered in the study are as follows:
Roche Diagnostics (India) , Tech4Life Enterprises (Canada)
Select User Access Type

Key Highlights of Report


May 2019 200 Pages 70 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Non-Invasive Glucose Meter Quantitative research analysis
Global Non-Invasive Glucose Meter Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Non-Invasive Glucose Meter Report?

Have a Query? Click Here

Other Related Reports

Intravascular Temperature Management Comprehensive Study by Type (Endovascular Cooling, Femoral Catheters), Application (Preoperative Care, Operative Care, Post-Operative Care), Medical Conditions (C...
$ 3750
Medical Radiation Shielding Comprehensive Study by Type (X-Ray, Shields, Booths, Sheet Lead, Bricks, Curtain), Application (Hospitals, Diagnostics Centers, Surgical Centers), Radiation (Particle Radi...
$ 3650
Rehabilitation Equipment Comprehensive Study by Type (Therapy Devices, Mobility Equipment (Walking Assist Devices, Wheelchairs and Scooters), Exercise Equipment, Body Support Devices (Patient Lifts, ...
$ 3800
Breathing Machines Comprehensive Study by Application (Hospitals & Clinics, Home Healthcare), Product Type (Asthma Nebulizers, PAP Machines (C-PAP Breathing Machines, BIPAP Breathing Machines), Respi...
$ 3650
Intravascular Cooling System Comprehensive Study by Application (Preoperative Care, Operative Care Units, Post-operative Care Units), End Users (Hospital, ASCs, Clinic), Medical Condition (Stroke, C...
$ 3450
Pressure Relief Devices Comprehensive Study by Type (Low tech devices (air filled mattresses, gel filled mattresses, foam based mattresses), High tech devices (Kinetic bed, dynamic air therapy bed)),...
$ 3450